Lungeinfektioner med nontuberkuløse mykobakterier

Andreas Arnholdt Pedersen; Victor Næstholt Dahl; Ole Hilberg; Anders Løkke Ottesen; Andreas Fløe

doi:10.61409/V06230603

Lungeinfektioner med nontuberkuløse mykobakterier

Translated title of the contribution: Pulmonary infections with nontuberculous mycobacteria

Andreas Arnholdt Pedersen, Victor Næstholt Dahl, Ole Hilberg, Anders Løkke Ottesen, Andreas Fløe

Aarhus University Hospital

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

Translated title of the contribution	Pulmonary infections with nontuberculous mycobacteria
Original language	Danish
Article number	V06230603
Journal	Ugeskrift for Læger
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V06230603
Publication status	E-pub ahead of print - 1. Apr 2024

Documents & Links

10.61409/V06230603Licence: CC BY-NC-ND

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{2c1200a809d64d7a9200742e67f7c4b6,

title = "Lungeinfektioner med nontuberkul{\o}se mykobakterier",

abstract = "This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.",

keywords = "Anti-Bacterial Agents/therapeutic use, Humans, Lung Diseases/drug therapy, Mycobacterium Infections, Nontuberculous/drug therapy, Nontuberculous Mycobacteria, Pneumonia",

author = "Pedersen, {Andreas Arnholdt} and Dahl, {Victor N{\ae}stholt} and Ole Hilberg and Ottesen, {Anders L{\o}kke} and Andreas Fl{\o}e",

year = "2024",

month = apr,

day = "1",

doi = "10.61409/V06230603",

language = "Dansk",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Lungeinfektioner med nontuberkuløse mykobakterier

AU - Pedersen, Andreas Arnholdt

AU - Dahl, Victor Næstholt

AU - Hilberg, Ole

AU - Ottesen, Anders Løkke

AU - Fløe, Andreas

PY - 2024/4/1

Y1 - 2024/4/1

N2 - This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

AB - This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

KW - Anti-Bacterial Agents/therapeutic use

KW - Humans

KW - Lung Diseases/drug therapy

KW - Mycobacterium Infections, Nontuberculous/drug therapy

KW - Nontuberculous Mycobacteria

KW - Pneumonia

U2 - 10.61409/V06230603

DO - 10.61409/V06230603

M3 - Tidsskriftartikel

C2 - 38606709

SN - 0041-5782

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

M1 - V06230603

ER -

Lungeinfektioner med nontuberkuløse mykobakterier

Abstract

Documents & Links

SDU Link

Fingerprint

Cite this